Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether 4 grams daily of mycophenolate
mofetil (MMF) results in a greater proportion of individuals adequately exposed as measured
by drug levels (area under the curve of > 40 mg*hr/L).